Literature DB >> 1208545

Vascular responses to plasma hypoosmolality in man.

H W Overbeck, M B Pamnani.   

Abstract

To study limb vascular responses to plasma hypoosmolality in man, we infused test solutions of hypoosmolar NaCl (145 mOsm/kg) and control solutions of isosmolar NaCl (290 mOsm/kg) into the brachial arteries of 14 mornotensive and 13 essential hypertensive patients. Limb blood pressures were monitored, limb blood flow was measured by indicator-dilution, and limb vascular resistance was calculated as mmHg/ml flow/min/100 cm3 limb volume. The infusions did not significantly change systemic plasma osmolality, sodium concentration, or blood pressure. Compared to control infusions, the hypoosmolar infusions decreased limb venous plasma osmolality and serum sodium concentrations by an average of 12 mOsm/kg and 7 mEq/1, respectively. Compared to control infusions, limb venous serum concentrations of potassium, calcium, magnesium, or blood hematocrit were not altered by the hypoosmolar infusions. In response to the hypoosmolar infusions, limb resistance increased by 28% in normotensives and by 26% in hypertensives. We conclude that the acute local vascular response to a small reduction in plasma osmolality in the limb of man is a large increase in vascular resistance. We found no evidence for abnormal responses to plasma hypoosmolality in essential hypertensives.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1208545     DOI: 10.3181/00379727-150-39030

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  2 in total

1.  Effect of osmolality on erythrocyte rheology and perfusion of an artificial microvascular network.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Jeroen S Goede; Sergey S Shevkoplyas
Journal:  Microvasc Res       Date:  2015-02-07       Impact factor: 3.514

2.  The effects of blood osmolality changes on cat carotid body chemoreceptors in vivo.

Authors:  R Gallego; C Belmonte
Journal:  Pflugers Arch       Date:  1979-05-15       Impact factor: 3.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.